20 August 2002 - U.S. Patent and Trademark Office

TM 336 OFFICIAL GAZETTE AUGUST 20, 2002
CLASS 5—(Continued).
SN 78-101,713. SAMUEL ENTERPRISES, INC., MARINA DEL
REY, CA. FILED 1-9-2002.
JOINT AND MUSCLE
RELEASE
NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO
USE JOINT AND MUSCLE, APART FROM THE MARK AS
SHOWN.
FOR DIETARY AND NUTRITIONAL SUPPLEMENTS,
ANALGESICS, ANESTHETICS, ANTIPRURITICS, ANTI-
PYRETICS, ANTIARTHRITICS, ANTIRHEUMATICS,
COUNTER-IRRITANTS AND HOMEOPATHIC PRE-
PARATIONS TO RELIEVE PAIN AND ITCHING (U.S.
CLS. 6, 18, 44, 46, 51 AND 52).
SN 78-102,749. LA JOLLA PHARMACEUTICAL COMPANY,
SAN DIEGO, CA. FILED 1-15-2002.
BENTRELA
FOR PHARMACEUTICAL PREPARATIONS FOR PRE-
VENTION AND TREATMENT OF ANTIBODY-
MEDIATED DISEASES, NAMELY, SYSTEMIC LUPUS
ERYTHEMATOUS, RH HEMOLYTIC DISEASE OF THE
NEWBORN, ANTIPHOSPHOLIPID ANTIBODY SYN-
DROME, GRAVE’S DISEASE, MYASTHENIA GRAVIS,
HASHIMOTO’S THYROIDITIS, PEMPHIGUS, AUTOIM-
MUNE HEMOLYTIC ANEMIA, AUTOIMMUNE
THROMBOCYTOPENIA PURPURA, ANTIBODY
MEDIATED INFERTILITY, SJOGRE’S SYNDROME,
MIXED CONNECTIVE TISSUE DISEASE, GLOMERULO-
NEPHRITIS AND GOODPASTURE’S SYNDROME (U.S.
CLS. 6, 18, 44, 46, 51 AND 52).
SN 78-102,811. LA JOLLA PHARMACEUTICAL COMPANY,
SAN DIEGO, CA. FILED 1-15-2002.
IPSILAR
FOR PHARMACEUTICAL PREPARATIONS FOR PRE-
VENTION AND/OR TREATMENT OF ANTIBODY-
MEDIATED DISEASES, NAMELY, SYSTEMIC LUPUS
ERYTHEMATOSUS, RH HEMOLYTIC DISEASE OF THE
NEWBORN, ANTIPHOSPHOLIPID ANTIBODY SYN-
DROME, GRAVE’S DISEASE, MYASTHENIA GRAVIS,
HASHIMOTO’S THYROIDITIS, PEMPHIGUS, AUTOIM-
MUNE HEMOLYTIC ANEMIA, AUTOIMMUNE
THROMBOCYTOPENIA PURPURA, ANTIBODY
MEDIATED INFERTILITY, SJOGRE’S SYNDROME,
MIXED CONNECTIVE TISSUE DISEASE, GLOMERULO-
NEPHRITIS AND GOODPASTURE’S SYNDROME (U.S.
CLS. 6, 18, 44, 46, 51 AND 52).
CLASS 5—(Continued).
SN 78-102,813. LA JOLLA PHARMACEUTICAL COMPANY,
SAN DIEGO, CA. FILED 1-15-2002.
LUARC
FOR PHARMACEUTICAL PREPARATIONS FOR PRE-
VENTION AND/OR TREATMENT OF ANTIBODY-
MEDIATED DISEASES, NAMELY, SYSTEMIC LUPUS
ERYTHEMATOSUS, RH HEMOLYTIC DISEASE OF THE
NEWBORN, ANTIPHOSPHOLIPID ANTIBODY SYN-
DROME, GRAVE’S DISEASE, MYASTHENIA GRAVIS,
HASHIMOTO’S THYROIDITIS, PEMPHIGUS, AUTOIM-
MUNE HEMOLYTIC ANEMIA, AUTOIMMUNE
THROMBOCYTOPENIA PURPURA, ANTIBODY
MEDIATED INFERTILITY, SJOGRE’S SYNDROME,
MIXED CONNECTIVE TISSUE DISEASE, GLOMERULO-
NEPHRITIS AND GOODPASTURE’S SYNDROME (U.S.
CLS. 6, 18, 44, 46, 51 AND 52).
SN 78-103,010. LA JOLLA PHARMACEUTICAL COMPANY,
SAN DIEGO, CA. FILED 1-16-2002.
SPRINZA
FOR PHARMACEUTICAL PREPARATIONS FOR PRE-
VENTION AND TREATMENT OF ANTIBODY-
MEDIATED DISEASES, NAMELY, SYSTEMIC LUPUS
ERYTHEMATOSUS, RH HEMOLYTIC DISEASE OF THE
NEWBORN, ANTIPHOSPHOLIPID ANTIBODY SYN-
DROME, GRAVE’S DISEASE, MYASTHENIA GRAVIS,
HASHIMOTO’S THYROIDITIS, PEMPHIGUS, AUTOIM-
MUNE HEMOLYTIC ANEMIA, AUTOIMMUNE
THROMBOCYTOPENIA PURPURA, ANTIBODY
MEDIATED INFERTILITY, SJOGRE’S SYNDROME,
MIXED CONNECTIVE TISSUE DISEASE, GLOMERULO-
NEPHRITIS AND GOODPASTURE’S SYNDROME (U.S.
CLS. 6, 18, 44, 46, 51 AND 52).
SN 78-103,187. BAYER CORPORATION, PITTSBURGH, PA.
FILED 1-17-2002.
TRIMAX
FOR INSECTICIDES, PESTICIDES AND HERBICIDES
FOR DOMESTIC, AGRICULTURAL, AND OTHER PRO-
FESSIONAL USE (U.S. CLS. 6, 18, 44, 46, 51 AND 52).
FIRST USE 4-17-2002; IN COMMERCE 4-17-2002.
SN 78-103,194. VITAQUEST INTERNATIONAL INC., WEST
CALDWELL, NJ. FILED 1-17-2002.
3-G
FOR DIETARY SUPPLEMENT (U.S. CLS. 6, 18, 44, 46,
51 AND 52).